CLOV vs RLAY
Clover Health Investments Corp (CLOV) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported RLAY revenue for 2024-12-31 was $10.0M. Net income was -$337.7M. Revenue was down 60.8% from 2023-12-31 to 2024-12-31. RLAY currently screens at market cap $3.39B.
CLOV currently screens at market cap $1.55B. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the CLOV and RLAY stock pages for the full models.
Not investment advice.